Please login (Members) to view content or
(Nonmembers) this article.
No votes yet

Shifting to a Biomarker Paradigm Across Cancer Care

Suzanne M. Mahon
CJON 2020, 24(6), 633-634 DOI: 10.1188/20.CJON.633-634

Precision medicine has revolutionized multiple facets of care across the cancer trajectory, from prevention through treatment. Sometimes referred to as personalized medicine, precision medicine uses information contained in an individual’s genes, as well as biomarkers and genetic alterations detected in tumor cells, to prevent, diagnose, and treat malignancy. It can provide valuable information about an individual’s risk for developing malignancy, facilitate an accurate diagnosis, inform or revise a plan of treatment, or offer information about prognosis.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or